Sebetralstat

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Sebetralstat (Ekterly) for treatment of hereditary angioedema attacks.

Sebetralstat (Ekterly) for treatment of hereditary angioedema attacks.

Journal: The Medical letter on drugs and therapeutics
Published: February 06, 2026

Correction to "Sebetralstat (KVD900): A Potent and Selective Small Molecule Plasma Kallikrein Inhibitor Featuring a Novel P1 Group as a Potential Oral On-Demand Treatment for Hereditary Angioedema".

Correction to "Sebetralstat (KVD900): A Potent and Selective Small Molecule Plasma Kallikrein Inhibitor Featuring a Novel P1 Group as a Potential Oral On-Demand Treatment for Hereditary Angioedema".

Journal: Journal of medicinal chemistry
Published: October 30, 2025

Sebetralstat: a paradigm shift in hereditary angioedema management.

Sebetralstat: a paradigm shift in hereditary angioedema management.

Journal: Annals of medicine and surgery (2012)
Published: September 18, 2025

Sebetralstat as a patient-centered alternative to lanadelumab: Insights from recent real-world evidence.

Sebetralstat as a patient-centered alternative to lanadelumab: Insights from recent real-world evidence.

Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: August 25, 2025

The power of a pill: Ekterly (Sebetralstat): first oral on-demand therapy for hereditary angioedema-a paradigm shift in treatment.

The power of a pill: Ekterly (Sebetralstat): first oral on-demand therapy for hereditary angioedema-a paradigm shift in treatment.

Journal: Annals of medicine and surgery (2012)
Published: August 24, 2025

Impact of Oral Sebetralstat on Anxiety Associated With Hereditary Angioedema Attacks.

Impact of Oral Sebetralstat on Anxiety Associated With Hereditary Angioedema Attacks.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: August 18, 2025

Self-administered oral sebetralstat: a game-changer in treatment of hereditary angioedema.

Self-administered oral sebetralstat: a game-changer in treatment of hereditary angioedema.

Journal: Annals of medicine and surgery (2012)
Published: August 13, 2025

Sebetralstat.

Sebetralstat.

Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Published: August 12, 2025

Sebetralstat: First Approval.

Sebetralstat: First Approval.

Journal: Drugs
Published: August 10, 2025

Novel drug approval by the FDA: Ekterly (Sebetralstat), oral plasma kallikrein inhibitor for treating acute attacks of hereditary angioedema.

Novel drug approval by the FDA: Ekterly (Sebetralstat), oral plasma kallikrein inhibitor for treating acute attacks of hereditary angioedema.

Journal: Annals of medicine and surgery (2012)
Published: July 31, 2025

Sebetralstat for On-Demand Treatment of Mucosal Hereditary Angioedema Attacks in KONFIDENT-S.

Sebetralstat for On-Demand Treatment of Mucosal Hereditary Angioedema Attacks in KONFIDENT-S.

Journal: Clinical and translational allergy
Published: July 31, 2025

Sebetralstat: FDA approves first oral on-demand therapy for hereditary angioedema.

Sebetralstat: FDA approves first oral on-demand therapy for hereditary angioedema.

Journal: Irish journal of medical science
Published: July 18, 2025
Showing 1-12 of 25

Last Updated: 04/28/2026